Search by Drug Name or NDC

NDC 54092-0256-02 Fosrenol 750 mg/1 Details

Fosrenol 750 mg/1

Fosrenol is a ORAL POWDER in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is LANTHANUM CARBONATE.

MedlinePlus Drug Summary

Lanthanum is used to reduce blood levels of phosphate in people with kidney disease. High levels of phosphate in the blood can cause bone problems. Lanthanum is in a clsas of medications called phosphate binders. It binds phosphorus that you get from foods in your diet and prevents it from being absorbed into your blood stream.

Related Packages: 54092-0256-02
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Lanthanum

Product Information

NDC	54092-0256
Product ID	54092-256_5624059d-27f2-44d4-a8dc-3eeba15446c8
Associated GPIs	52800045203030
GCN Sequence Number	069415
GCN Sequence Number Description	lanthanum carbonate POWD PACK 750 MG ORAL
HIC3	C1A
HIC3 Description	ELECTROLYTE DEPLETERS
GCN	32453
HICL Sequence Number	026756
HICL Sequence Number Description	LANTHANUM CARBONATE
Brand/Generic	Brand
Proprietary Name	Fosrenol
Proprietary Name Suffix	n/a
Non-Proprietary Name	lanthanum carbonate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	POWDER
Route	ORAL
Active Ingredient Strength	750
Active Ingredient Units	mg/1
Substance Name	LANTHANUM CARBONATE
Labeler Name	Takeda Pharmaceuticals America, Inc.
Pharmaceutical Class	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA204734
Listing Certified Through	2024-12-31

Package

NDC 54092-0256-02 (54092025602)

Pricing Information	N/A
NDC Package Code	54092-256-02
Billing NDC	54092025602
Package	9 CARTON in 1 PACKAGE (54092-256-02) / 10 POWDER in 1 CARTON (54092-256-01)
Marketing Start Date	2014-09-24
NDC Exclude Flag	N